
From my daily American Association for Justice newsletter –
US officials say e-cigarettes cannot be allowed to become a conduit for teenage addiction.
In a Washington Post (10/11, 12.5M) op-ed, HHS Secretary Alex M. Azar and FDA Commissioner Scott Gottlieb write that they are “deeply concerned about the risks that e-cigarettes pose for children, given how quickly teenage use of these products has accelerated.” Azar and Gottlieb say it is “crucial that e-cigarettes do not become an on-ramp for children to become addicted to nicotine. But at the same time, we believe e-cigarettes can be an important off-ramp for adults who are addicted to combustible cigarettes.” The duo add that they “know that the steps we have taken thus far are not enough. We are considering limits on the marketing and features of e-cigarettes to reverse their appeal and availability to minors. We are also actively reconsidering our policy under which certain e-cigarettes – particularly the products with flavors that might appeal to children – can remain on the market without submitting a premarket application to the FDA until 2022.”
FDA warns e-cigarette manufacturer over selling liquids containing erectile dysfunction meds.
The Philadelphia Inquirer (10/11, Schaefer, 928K) reports the FDA issued a warning letter on Thursday to e-cigarette maker HelloCig Electronic Technology after the agency found that it was selling the prescription erectile dysfunction drugs tadalafil and/or sildenafil in e-liquid form. FDA Commissioner Scott Gottlieb announced, “There are no e-liquids that contain prescription drugs that have been proven safe or effective through this route of administration.”
The Washington Examiner (10/11, King, 299K) reports the FDA statement accompanying the warning letter said, “These FDA-approved prescription drugs are not approved for inclusion in e-liquid products sold over the counter and are therefore being sold illegally.”
MedPage Today (10/11, Boyles, 52K) reports Gottlieb added, “There are no e-liquid products approved to contain prescription drugs or any other medications that require a doctor’s supervision.”